PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO). As a reputable CRO providing preclinical pharmacology services to clients worldwide, PharmaLegacy’s acquisition of BTS Research is an important step in its continuing growth. San Diego is a significant global R&D hub and the acquisition allows PharmaLegacy to join the greater community while also strengthening and expanding PharmaLegacy’s global research capabilities and service offerings.
Read the full article: PharmaLegacy Acquires Preclinical CRO BTS Research, Strengthening Its Preclinical Services and Expanding Laboratory Operations into North America //
Source: https://www.businesswire.com/news/home/20240911608201/en/PharmaLegacy-Acquires-Preclinical-CRO-BTS-Research-Strengthening-Its-Preclinical-Services-and-Expanding-Laboratory-Operations-into-North-America